The unsung heroes in North Carolina's fight against measles are working tirelessly behind the scenes in Raleigh! As the state grapples with an alarming rise in measles cases, critical decisions that protect us all are being made deep within the State Laboratory of Public Health. This isn't just about identifying the virus; it's about how quickly we're alerted, how effectively we're protected, and how we can stop this highly contagious disease in its tracks.
Since December 2025, North Carolina has seen at least 23 confirmed measles cases. For many of these, the journey from suspicion to confirmation begins at this vital lab. Dr. Scott Shone, the Laboratory Director, explained that when a healthcare provider suspects measles, they first consult with the public health division's experts. If the case is deemed high-risk, the sample is fast-tracked to his lab. "We have a very rapid turnaround time," Dr. Shone emphasized, noting that samples can arrive and be processed within just a few hours.
This speed is absolutely crucial. Why? Because for individuals exposed to measles, time is of the essence. Unvaccinated people might be eligible for a vaccination within 72 hours of exposure, or an antibody treatment within six days, depending on their specific risk factors. Missing these windows could mean a greater chance of falling ill.
But here's where it gets even more intense: Measles is one of the most contagious viruses known to humankind. The virus particles can linger in the air for hours after an infected person has left a room. Imagine that – a room could be infectious long after the person is gone!
Once a sample arrives at the lab, it enters a highly controlled environment. Technicians, working within biosafety cabinets, carefully handle respiratory swabs and sometimes urine samples. They then use advanced techniques, like Polymerase Chain Reaction (PCR) technology, to analyze the genetic material of the virus and confirm its presence. The lab even validated urine testing for measles last year, adding another powerful tool to their arsenal.
Every step is meticulously designed to prevent contamination. Samples move through separate rooms with strict airflow controls, ensuring the integrity of the results and the safety of the staff. The lab is equipped to handle a significant volume, with specialized 'bio robots' capable of processing up to 96 samples at a time. This scalability is vital, as Dr. Shone pointed out, "Some of our neighboring states and other states across the country have gotten dozens to hundreds of cases in a pretty short order, so we need to be able to scale up our response appropriately."
To prepare for potential surges, the lab is not only bringing new equipment online in renovated spaces but also cross-training its staff. "Whether it’s herpes virus, chickenpox, flu, COVID, measles – this team responds to that," Dr. Shone said. They understand the importance of not overwhelming the team that handles other critical testing, ensuring a robust response to any outbreak. "The lesson we learned from the pandemic... is that it is a lot easier to prepare for these during peacetime than when you're in the middle of the war against these viruses."
And this is the part most people miss: When the state lab confirms a measles case, their work isn't done. Positive samples are sent to the Centers for Disease Control and Prevention (CDC) in Atlanta for genetic sequencing. This process is key to understanding if cases in different regions are connected or if the virus is evolving. "With every measles case we continue to see, it puts that designation [of measles elimination] at risk," Dr. Shone warned.
This genetic information is what guides public health officials in their response, helping them track the virus's spread and origins. The U.S. has maintained its measles elimination status since 2000, but recent outbreaks are a stark reminder of how fragile that achievement can be.
Health officials continue to stress that vaccination is the most powerful shield against measles. Two doses of the MMR vaccine offer an impressive 97% lifetime protection. Measles itself has no cure and can be particularly severe for young children, potentially leading to serious complications like encephalitis (brain swelling) and pneumonia, often requiring hospitalization.
While the vaccine is typically recommended for children 12 months and older, NCDHHS is now urging families in outbreak areas to consult their pediatricians about the possibility of earlier vaccination. What are your thoughts on the importance of timely vaccination during an outbreak? Do you believe the U.S. can maintain its measles elimination status with the current trends? Share your opinions below!
